Localized targeting of biomaterials following myocardial infarction: A foundation to build on

Trends in Cardiovascular Medicine

Volumn 23, Issue 8, 2013, Pages 301-311

  Shuman, James A ^a   Zurcher, Jonathan R ^a   Sapp, Ashley A ^a   Burdick, Jason A ^c   Gorman, Robert C ^c   Gorman, Joseph H ^d   Goldsmith, Edie C ^a   Spinale, Francis G ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WJB Dorn VA Medical Center   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BIOMATERIAL; COLLAGEN; FIBRIN; HYDROXYAPATITE; MATRIX METALLOPROTEINASE; NANOPARTICLE; POLYMER;

BIODEGRADATION; CELL PROLIFERATION; CELL VIABILITY; CHEMICAL COMPOSITION; CHEMOTAXIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE WALL; HEART VENTRICLE REMODELING; HUMAN; HYDROGEL; INJECTION; MESENCHYMAL STEM CELL; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; REVIEW;

BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; EXTRACELLULAR MATRIX; HUMANS; MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; VENTRICULAR REMODELING;

EID: 84884813269     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.04.004     Document Type: Review

References (77)

1. Baum J., Duffy H.S. Fibroblasts and myofibroblasts: what are we talking about?. Journal of Cardiovascular Pharmacology 2011, 57(4):376-379.
2. Chachques J.C., Trainini J.C., Lago N., Cortes-Morichetti M, Schussler O, Carpentier A Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study. Annals of Thoracic Surgery 2008, 85(3):901-908.
3. Chachques J.C., Trainini J.C., Lago N., Masoli O.H., Barisani J.L., Cortes-Morichetti M., et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplantation 2007, 16(9):927-934.
4. Chen Q.Z., Ishii H., Thouas G.A., Lyon A.R., Wright J.S., Blaker J.J., et al. An elastomeric patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the heart. Biomaterials 2010, 31(14):3885-3893. [Epub 2010 Feb 11].
5. Christman K.L., Fok H.H., Sievers R.E., Fang Q., Lee R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Engineering 2004, 10(3-4):403-409.
6. Christman K.L., Lee R.J. Biomaterials for the treatment of myocardial infarction. Journal of the American College of Cardiology 2006, 48(5):907-913. [Epub 2006 Aug 17. PMID: 16949479].
7. Dai W., Wold L.E., Dow J.S., Kloner R.A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. Journal of the American College of Cardiology 2005, 46(4):714-719.
8. Dang A.B., Guccione J.M., Mishell J.M., Zhang P., Wallace A.W., Gorman R.C., et al. Akinetic myocardial infarcts must contain contracting myocytes: finite-element model study. American Journal of Physiology Heart and Circulatory Physiology 2005, 288(4):H1844-H1850. [Epub 2004 Dec 16. PMID: 15604126].
9. Danoviz M.E., Nakamuta J.S., Marques F.L., dos Santos L., Alvarenga E.C., dos Santos A.A., et al. Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention. PLoS One 2010, 5(8):e12077.
10. Darby I., Skalli O., Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Laboratory Investigation 1990, 63(1):21-29.
11. Dixon J.A., Gorman R.C., Stroud R.E., Mukherjee R., Meyer E.C., Baker N.L., et al. Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways. Circulation 2011, 124(Suppl. 11):S35-S45.
12. Dixon J.A., Spinale F.G. Myocardial remodeling: cellular and extracellular events and targets. Annual Review of Physiology 2011, 73:47-68. [PMID: 21314431].
13. Dobner S., Bezuidenhout D., Govender P., Zilla P., Davies N. A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling. Journal of Cardiac Failure 2009, 15(7):629-636. [Epub 2009 May 7].
14. Dvir T., Bauer M., Schroeder A., Tsui J.H., Anderson D.G., Langer R., et al. Nanoparticles targeting the infarcted heart. Nano Letters 2011, 11(10):4411-4414. [Epub 2011 Sep 14].
15. Ertl G., Frantz S. Healing after myocardial infarction. Cardiovascular Research 2005, 66(1):22-32.
16. Frangogiannis N.G., Michael L.H., Entman M.L. Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovascular Research 2000, 48(1):89-100.
17. Frangogiannis N.G. The immune system and cardiac repair. Pharmacological Research 2008, 58(2):88-111. [Epub 2008].
18. Frangogiannis N.G. The mechanistic basis of infarct healing. Antioxidants & Redox Signaling 2006, 8:1907-1939.
19. Frantz S., Bauersachs J., Ertl G. Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovascular Research 2009, 81(3):474-481. [Epub 2008 Oct 31].
20. Fujimoto K.L., Ma Z., Nelson D.M., Hashizume R., Guan J., Tobita K., et al. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials 2009, 30(26):4357-4368. [Epub 2009].
21. Garbern J.C., Minami E., Stayton P.S., Murry C.E. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials 2011, 32(9):2407-2416. [Epub 2010].
22. Giraud M.N., Guex A.G., Tevaearai H.T. Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies. Cardiology Research and Practice 2012, [Epub 2012 Apr 22].
23. Gorman R.C., Jackson B.M., Burdick J.A., Gorman J.H. Infarct restraint to limit adverse ventricular remodeling. Journal of Cardiovascular Translational Research 2011, 4(1):73-81. [Epub 2010].
24. Guccione J.M., Moonly S.M., Moustakidis P., Costa K.D., Moulton M.J., Ratcliffe M.B., et al. Mechanism underlying mechanical dysfunction in the border zone of left ventricular aneurysm: a finite element model study. Annals of Thoracic Surgery 2001, 71(2):654-662.
25. Hao X., Silva E.A., Månsson-Broberg A., Grinnemo K.H., Siddiqui A.J., Dellgren G., et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovascular Research 2007, 75(1):178-185. [Epub 2007 Apr 6].
26. Hatam N., Amerini A.L., Steiner F., Lazeroms M., Mischke K., Schauerte P., et al. Video-assisted pericardioscopic surgery: refinement of a new technique for implanting epimyocardial pacemaker leads. European Journal of Cardio-thoracic Surgery 2011, 39(3):335-341. [Epub 2010].
27. Holladay C.A., Duffy A.M., Chen X., Sefton M.V., O'Brien T.D., Pandit A.S. Recovery of cardiac function mediated by MSC and interleukin-10 plasmid functionalised scaffold. Biomaterials 2012, 33(5):1303-1314. [Epub 2011 Nov 10].
28. Ifkovits J.L., Tous E., Minakawa M., Morita M., Robb J.D., Koomalsingh K.J., et al. Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(25):11507-11512.
29. Iwakura A., Fujita M., Kataoka K., Tambara K., Sakakibara Y., Komeda M., et al. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart and Vessels 2003, 18(2):93-99. [PMID: 12756606].
30. Jain P.K., Huang X., El-Sayed I.H., El-Sayed M.A. Nobel metals on the nanoscale: optical and photothermal properties and some application in imaging, sensing, biology and medicine. Accounts of Chemical Research 2008, 41:1578-1586.
31. Jaroszewski D.E., Altemose G.T., Scott L.R., Srivasthan K., Devaleria P.A., Lackey J., et al. Nontraditional surgical approaches for implantation of pacemaker and cardioverter defibrillator systems in patients with limited venous access. Annals of Thoracic Surgery 2009, 88(1):112-116.
32. Kang K., Sun L., Xiao Y., Li S.H., Wu J., Guo J., et al. Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration. Journal of the American College of Cardiology 2012, 60(21):2237-2249.
33. Kim J., Kim I.S., Cho T.H., Kim H.C., Yoon S.J., Choi J., et al. In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering. Journal of Biomedical Materials Research Part A 2010, 95(3):673-681.
34. Kofidis T., de Bruin J.L., Hoyt G.L., Lebl D.R., Tanaka M., Yamane T., et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. Journal of Thoracic and Cardiovascular Surgery 2004, 128(4):571-578.
35. Kraehenbuehl T.P., Ferreira L.S., Hayward A.M., Nahrendorf M., van der Vlies A.J., Vasile E., et al. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 2011, 32(4):1102-1109. [Epub 2010 Oct 28].
36. Landa N., Miller L., Feinberg M.S., Holbova R., Shachar M., Freeman I., et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008, 117(11):1388-1396. [Epub 2008 Mar 3].
37. Lee R.J., Hinson A., Helgerson S., Bauernschmitt R., Sabbah H.N. Polymer-based restoration of left ventricular mechanics. Cell Transplantation 2012, 28.
38. Leor J., Tuvia S., Guetta V., Manczur F., Castel D., Willenz U., et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine. Journal of the American College of Cardiology 2009, 54(11):1014-1023.
39. LoneStar Heart, Inc. A randomized, controlled study to evaluate Algisyl-LVR™ as a method of left ventricular augmentation for heart failure (AUGMENT-HF). 2011-2012. In: ClinicalTrials.gov. Available from:. NLM Identifier: NCT01311791. http://clinicaltrials.gov/ct2/show/NCT01311791.
40. Macarthur J.W., Trubelja A., Shudo Y., Hsiao P., Fairman A.S., Yang E., et al. Mathematically engineered stromal cell-derived factor-1α stem cell cytokine analog enhances mechanical properties of infarcted myocardium. Journal of Thoracic and Cardiovascular Surgery 2013, 145(1):278-284.
41. Morita M., Eckert C.E., Matsuzaki K., Noma M., Ryan L.P., Burdick J.A., et al. Modification of infarct material properties limits adverse ventricular remodeling. Annals of Thoracic Surgery 2011, 92(2):617-624.
42. Mukherjee R., Zavadzkas J.A., Saunders S.M., McLean J.E., Jeffords L.B., Beck C., et al. Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Annals of Thoracic Surgery 2008, 86(4):1268-1276.
43. Nakamuta J.S., Danoviz M.E., Marques F.L., dos Santos L., Becker C., Gonçalves G.A., et al. Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLoS One 2009, 4(6):e6005.
44. Okada M., Payne T.R., Oshima H., Momoi N., Tobita K., Huard J. Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials 2010, 31(30):7678-7683. [Epub 2010].
45. Papiashvilli M., Haitov Z., Fuchs T., Bar I. Left ventricular epicardial lead implantation for resynchronisation therapy using a video-assisted thoracoscopic approach. Heart, Lung & Circulation 2011, 20(4):220-222. [Epub 2010 Dec 10].
46. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81(4):1161-1172.
47. Poobalarahi F., Baicu C.F., Bradshaw A.D. Cardiac myofibroblasts differentiated in 3D culture exhibit distinct changes in collagen I production, processing, and matrix deposition. American Journal of Physiology Heart and Circulatory Physiology 2006, 291(6):H2924-H2932.
48. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacology and Therapeutics 2009, 123(2):255-278. [Epub 2009 May 19].
49. Purcell B.P., Elser J.A., Mu A., Margulies K.B., Burdick J.A. Synergistic effects of SDF-1α chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. Biomaterials 2012, 33(31):7849-7857.
50. Rane A.A., Chuang J.S., Shah A., Hu D.P., Dalton N.D., Gu Y., et al. Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction. PLoS One 2011, 6(6):e21571. [Epub 2011 Jun 23].
51. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123(4):e18-e209.
52. Ruvinov E., Leor J., Cohen S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 2011, 32(2):565-578.
53. Ryan L.P., Matsuzaki K., Noma M., Jackson B.M., Eperjesi T.J., Plappert T.J., et al. Dermal filler injection: a novel approach for limiting infarct expansion. Annals of Thoracic Surgery 2009, 87(1):148-155.
54. Santiago J.J., Dangerfield A.L., Rattan S.G., Bathe K.L., Cunnington R.H., Raizman J.E., et al. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Developmental Dynamics 2010, 239:1573-1584.
55. Seliktar D., Zisch A.H., Lutolf M.P., Wrana J.L., Hubbell J.A. MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. Journal of Biomedical Materials Research Part A 2004, 68(4):704-716. [PMID: 14986325].
56. Singelyn J.M., Sundaramurthy P., Johnson T.D., Schup-Magoffin P.J., Hu D.P., Faulk D.M., et al. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. Journal of the American College of Cardiology 2012, 59(8):751-763.
57. Sisco P.N., Wilson C.G., Mironova E., Baxter S.C., Murphy C.J., Goldsmith E.C. The effect of gold nanorods on cell-mediated collagen remodeling. Nano Letters 2008, 8:3409-3412.
58. Solis J., Levine R.A., Johnson B., Guerrero J.L., Handschumacher M.D., Sullivan S., et al. Polymer injection therapy to reverse remodel the papillary muscles: efficacy in reducing mitral regurgitation in a chronic ischemic model. Circulation: Cardiovascular Interventions 2010, 3(5):499-505.
59. Souders C.A., Bowers S.L., Baudino T.A. Cardiac fibroblast: the renaissance cell. Circulation Research 2009, 105(12):1164-1176.
60. Spinale F.G., Janicki J.S., Zile M.R. Invited review: membrane associated matrix proteolysis and heart failure. Circulation Research 2013, 112(1):195-208.
61. Spinale F.G. Matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiological Reviews 2007, 87(4):1285-1342.
62. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechanoregulation of connective tissue remodeling. Nature Reviews Molecular Cell Biology 2002, 3:349-363.
63. Tous E., Ifkovits J.L., Koomalsingh K.J., Shuto T., Soeda T., Kondo N., et al. Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. Biomacromolecules 2011, 12(11):4127-4135. [Epub 2011 Oct 11].
64. Tous E., Weber H.M., Lee M.H., Koomalsingh K.J., Shuto T., Kondo N., et al. Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking. Acta Biomaterialia 2012, 8(9):3218-3227. [Epub 2012 May 29].
65. Vale P.R., Losordo D.W., Milliken C.E., McDonald M.C., Gravelin L.M., Curry C.M., et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 2001, 103:2138-2143.
66. Vale P.R., Losordo D.W., Tkebuchava T., Chen D., Milliken C.E., Isner J.M. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. Journal of the American College of Cardiology 1999, 34:246-254.
67. Wall S.T., Walker J.C., Healy K.E., Ratcliffe M.B., Guccione J.M. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 2006, 114(24):2627-2635. [Epub 2006 Nov 27. PMID: 17130342].
68. Wang J., Chen H., Seth A., McCulloch C.A. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. American Journal of Physiology-Heart and Circulatory Physiology 2003, 285:H1871-H1881.
69. Webber M.J., Matson J.B., Tamboli V.K., Stupp S.I. Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response. Biomaterials 2012, 33(28):6823-6832. [Epub 2012 Jun 28].
70. Weir R.A., McMurray J.J., Velazquez E.J. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. American Journal of Cardiology 2006, 97(10 A):13F-25F.
71. Wenk J.F., Eslami P., Zhang Z., Xu C., Kuhl E., Gorman JH, et al. A novel method for quantifying the in-vivo mechanical effect of material injected into a myocardial infarction. Annals of Thoracic Surgery 2011, 92(3):935-941.
72. Widgerow A.D. Cellular/extracellular matrix cross-talk in scar evolution and control. Wound Repair and Regeneration 2011, 19(2):117-133. [PMID: 21362079].
73. Wilson C.G., Sisco P.N., Gadala-Maria F.A., Murphy C.J., Goldsmith E.C. Polyelectrolyte-coated gold nanorods and their interactions with type I collagen. Biomaterials 2009, 30:5639-5648.
74. Wilson C.G., Sisco P.N., Goldsmith E.C., Murphy C.J. Glycosaminoglycan-functionalized gold nanorods: interaction with cardiac cells and type I collagen. Journal of Materials Chemistry 2009, 19:6332-6340.
75. Wu J., Zeng F., Huang X.P., Chung J.C., Konecny F., Weisel R.D., et al. Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. Biomaterials 2011, 32(2):579-586.
76. Yeh Y.C., Lee W.Y., Yu C.L., Hwang S.M., Chung M.F., Hsu L.W., et al. Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model. Biomaterials 2010, 31(25):6444-6453.
77. Yu J., Gu Y., Du K.T., Mihardja S., Sievers R.E., Lee R.J. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials 2009, 30(5):751-756. [Epub 2008 Nov 17].